98 related articles for article (PubMed ID: 15248900)
1. Beckman Access versus the Bayer ACS:180 and the Abbott AxSYM cardiac Troponin-I real-time immunoassays: an observational prospective study.
Baevsky RH; Kapur RK; Smithline HA
BMC Emerg Med; 2004 Jul; 4(1):2. PubMed ID: 15248900
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system.
Storti S; Prontera C; Parri MS; Iervasi A; Vittorini S; Emdin M; Zucchelli GC; Longombardo G; Migliorini P; Clerico A
Clin Chem Lab Med; 2006; 44(8):1022-9. PubMed ID: 16879072
[TBL] [Abstract][Full Text] [Related]
3. Performance of the enhanced Abbott AxSYM cardiac troponin I reagent in patients with heterophilic antibodies.
Yeo KT; Storm CA; Li Y; Jayne JE; Brough T; Quinn-Hall KS; Fitzmaurice TF
Clin Chim Acta; 2000 Feb; 292(1-2):13-23. PubMed ID: 10686273
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 6 cardiac troponin assays in patients with acute coronary syndrome.
Saadeddin SM; Habbab MA; Siddieg HH; Al Seeni MN; Tahery AB; Dafterdar RM
Saudi Med J; 2003 Oct; 24(10):1092-7. PubMed ID: 14578975
[TBL] [Abstract][Full Text] [Related]
5. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
[TBL] [Abstract][Full Text] [Related]
6. Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance.
Korley FK; Schulman SP; Sokoll LJ; DeFilippis AP; Stolbach AI; Bayram JD; Saheed MO; Omron R; Fernandez C; Lwin A; Cai SS; Post WS; Jaffe AS
Acad Emerg Med; 2014 Jul; 21(7):727-35. PubMed ID: 25112512
[TBL] [Abstract][Full Text] [Related]
7. False-positive troponin I measured with the Abbott AxSYM attributed to fibrin interference.
Kazmierczak SC; Sekhon H; Richards C
Int J Cardiol; 2005 May; 101(1):27-31. PubMed ID: 15860379
[TBL] [Abstract][Full Text] [Related]
8. The lack of standardization of cardiac troponin I assay systems.
Tate JR; Heathcote D; Rayfield J; Hickman PE
Clin Chim Acta; 1999 Jun; 284(2):141-9. PubMed ID: 10451241
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of low-positive troponin I by AxSYM and ACS:180.
Lewis JS; Taylor JF; Miklos AZ; Virgo KS; Creer MH; Ritter DG
Am J Clin Pathol; 2001 Sep; 116(3):396-402. PubMed ID: 11554168
[TBL] [Abstract][Full Text] [Related]
10. The comparative analytical performance of four troponin I assays at low concentration.
Koerbin G; Tate JR; Potter JM; Hickman PE
Ann Clin Biochem; 2005 Jan; 42(Pt 1):19-23. PubMed ID: 15802028
[TBL] [Abstract][Full Text] [Related]
11. Analytical and clinical performance of two cardiac troponin I immunoassays.
Zaman Z; De Spiegeleer S; Gerits M; Blanckaert N
Clin Chem Lab Med; 1999 Sep; 37(9):889-97. PubMed ID: 10596955
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory.
Taylor P; Pickard G; Gammie A; Atkins M
J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?
Bargnoux AS; Kuster N; Patrier L; Dupuy AM; Tachon G; Maurice F; Badaoui B; Chalabi L; Badiou S; Deleuze S; Leray-Moragues H; Morena M; Canaud B; Cristol JP
Clin Chem Lab Med; 2016 Apr; 54(4):673-82. PubMed ID: 26457775
[TBL] [Abstract][Full Text] [Related]
14. Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease.
Hickman PE; Koerbin G; Southcott E; Tate J; Dimeski G; Carter A; McGill D; Talaulikar G; Potter JM
Ann Clin Biochem; 2007 May; 44(Pt 3):285-9. PubMed ID: 17456297
[TBL] [Abstract][Full Text] [Related]
15. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.
Peetz D; Schweigert R; Jachmann N; Post F; Schinzel H; Lackner KJ
Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892
[TBL] [Abstract][Full Text] [Related]
16. Positive interference from contrast media in cardiac troponin I immunoassays.
Lin CT; Lee HC; Voon WC; Yen HW; Tang MH; Chin TT; Chen WR; Chien WT; Lai WT; Sheu SH
Kaohsiung J Med Sci; 2006 Mar; 22(3):107-13. PubMed ID: 16602274
[TBL] [Abstract][Full Text] [Related]
17. Towards a consistent definition of a significant delta troponin with z-scores: a way out of chaos?
Pretorius CJ; Cullen L; Parsonage WA; Greenslade JH; Tate JR; Wilgen U; Ungerer JP
Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):149-57. PubMed ID: 24381095
[TBL] [Abstract][Full Text] [Related]
18. Performance evaluation of a new chemiluminescent cardiac troponin I assay.
Dasgupta A; Chow L; Nazareno L; Tso G; Datta P
J Clin Lab Anal; 2000; 14(5):224-9. PubMed ID: 11018801
[TBL] [Abstract][Full Text] [Related]
19. Falsely elevated cardiac troponin-I in patients with seropositive rheumatoid arthritis.
Kenny PR; Finger DR
J Rheumatol; 2005 Jul; 32(7):1258-61. PubMed ID: 15996061
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Abbott AxSYM, Behring Opus Plus, DPC Immulite and Ortho-Clinical Diagnostics Vitros ECi for measurement of cardiac troponin I.
Kao JT; Wong IL; Lee JY; Chen RC
Ann Clin Biochem; 2001 Mar; 38(Pt 2):140-6. PubMed ID: 11269755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
